Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas

enthalten in: bioRxiv.org | 2021

by Aleta, A. | Martín-Corral, D. | Bakker, M. | +11

BAYESIAN GROUP TESTING WITH DILUTION EFFECTS

enthalten in: bioRxiv.org | 2021

by Tatsuoka, C. | Chen, W. | Lu, X.

Underlying co morbidity reveals unique immune signatures in Type II diabetes patients infected with SARS-CoV2

enthalten in: bioRxiv.org | 2021

by Sengupta, S. | Bhattacharya, G. | Chatterjee, S. | +10

The impact of environmental mycobiomes on geographic variation in COVID-19 mortality

enthalten in: bioRxiv.org | 2021

by Ladau, J. | Abuabara, K. | Walker, A. | +13

Reduced sensitivity of SARS-CoV-2 Omicron variant to booster-enhanced neutralization

enthalten in: bioRxiv.org | 2021

by Yu, X. | Wei, D. | Xu, W. | +6

Measurement of the extent of Anxiety and Depression that has occurred in college students due to the COVID 19 pandemic: A Survey based cross-secConal study

enthalten in: bioRxiv.org | 2021

by Goswami, S. | Chakraborty, S. | Chakraborty, A.

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617

enthalten in: bioRxiv.org | 2021

by Peng, L. | Hu, Y. | Mankowski, M. | +21

Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods

enthalten in: bioRxiv.org | 2021

by Bays, D. | Whiteley, T. | Pindar, M. | +5

SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccination

enthalten in: bioRxiv.org | 2021

by Peter, J. | Wegner, F. | Gsponer, S. | +25

Population immunity to SARS-CoV-2 in US states and counties due to infection and vaccination, January 2020-November 2021

enthalten in: bioRxiv.org | 2021

by Klaassen, F. | Chitwood, M. | Cohen, T. | +5